
A Pharmacological Analysis of Dayquil’s Active Ingredients in the Symptomatic Management of Adenovirus Infection
Introduction Adenoviruses are a ubiquitous class of non-enveloped DNA viruses that represent a significant etiologic agent of acute respiratory illnesses in humans.1 These infections manifest across a wide clinical spectrum, ranging from the mild symptoms of the common cold to more severe conditions such as bronchitis and pneumonia.3The clinical presentation of a viral infection, including that caused by adenovirus, is not solely a result of direct viral cytotoxicity but is largely a consequence of the host’s innate immune and inflammatory response to the pathogen. This response, while crucial for viral clearance, generates the familiar and distressing symptom cluster of fever, pain,





















